The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Stein, M. D.
* Articles by Miller, I.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Stein, M. D.
* Articles by Miller, I.
Related Collections
* AIDS/HIV
* Cocaine
* Opioids
* Depression
Am J Psychiatry 160:1659-1662, September 2003
© 2003 American Psychiatric Association


Article

Depression Severity and Drug Injection HIV Risk Behaviors

Michael D. Stein, M.D., David A. Solomon, M.D., Debra S. Herman, Ph.D., Bradley J. Anderson, Ph.D., and Ivan Miller, Ph.D.

OBJECTIVE: This study examined the association of depression severity and drug injection HIV risk behavior among injection drug users. METHOD: Injection drug users who met the DSM-IV criteria for major depressive disorder, dysthymia, or substance-induced mood disorder lasting at least 3 months were asked how often they used "needles or syringes that someone else had used" (injection risk behavior) in the past 90 days. Depression severity was measured by using the Modified Hamilton Rating Scale for Depression. RESULTS: Of the 109 subjects, 63% were male, 82% were Caucasian, and 10% were HIV positive. The subjects’ mean modified Hamilton depression scale score was 21.0 (SD=3.9). The mean number of reported instances of injection risk behavior (needle sharing) in the past 90 days was 57.5 (SD=134.7). In a logistic regression analysis in which the effects of age, race, gender, number of days on which injection drugs were used (injection days), and average number of injections per injection day were controlled, depression severity was associated with injection risk (odds ratio=1.5; 95% confidence interval=1.1–2.3). CONCLUSIONS: Greater severity of depression is associated with greater frequency of injection risk behavior among depressed injection drug users. Risk reduction programs that target depressed injection drug users need to be designed.




This article has been cited by other articles:


Home page
Am. J. PsychiatryHome page
J. SHI
Depression Severity and HIV Risk Behavior
Am J Psychiatry, May 1, 2004; 161(5): 929 - 929.
[Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
M. D. Stein, D. A. Solomon, D. S. Herman, J. L. Anthony, S. E. Ramsey, B. J. Anderson, and I. W. Miller
Pharmacotherapy Plus Psychotherapy for Treatment of Depression in Active Injection Drug Users
Arch Gen Psychiatry, February 1, 2004; 61(2): 152 - 159.
[Abstract] [Full Text] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 2003 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org